Cytarabine and Derivatives
DBCAT005237Pharmacologic class
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. A DrugBank category of 1 drug.
- Also known as
- Cytarabine Derivative · Cytarabine Derivatives · Cytosine arabinoside
- Drugs
What you can answer from here — as of January 27, 2021
1DrugEach linked to its full drug cardListed above
Which Cytarabine and Derivatives are approved where, and how do their indications and safety profiles compare?
Create a free account or log in to explore the full data card.
Create Account